November 7, 2026

Evan Lee Salim

The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma the-psychedelic-frontier-eli-lillys-3-8-billion-bet-on-ataibeckley-signals-a-new-era-for-big-pharma

The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma

Evan Lee Salim July 16, 2026
In a move that marks a tectonic shift in the pharmaceutical landscape, Eli Lilly has announced its...
Read More Read more about The Psychedelic Frontier: Eli Lilly’s $3.8 Billion Bet on AtaiBeckley Signals a New Era for Big Pharma
FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance fda-approves-gedatolisib-revtorpyk-for-advanced-hr-her2-breast-cancer-a-new-paradigm-in-overcoming-endocrine-resistance

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Evan Lee Salim July 16, 2026
The landscape of metastatic breast cancer treatment has reached a significant milestone with the U.S. Food and...
Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance
Recalculating the Path: How Personalized Support Systems Navigate the Uncertainty of a Cancer Diagnosis recalculating-the-path-how-personalized-support-systems-navigate-the-uncertainty-of-a-cancer-diagnosis

Recalculating the Path: How Personalized Support Systems Navigate the Uncertainty of a Cancer Diagnosis

Evan Lee Salim July 14, 2026
By Investigative Desk | April 16, 2026 For millions of patients, a cancer diagnosis is not merely...
Read More Read more about Recalculating the Path: How Personalized Support Systems Navigate the Uncertainty of a Cancer Diagnosis
Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data revolutionizing-hit-id-ginkgo-tangible-and-inductive-bio-launch-adme-one-to-front-load-pharmacokinetic-data

Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data

Evan Lee Salim July 12, 2026
In the high-stakes arena of drug discovery, the timeline from a promising hit to a viable clinical...
Read More Read more about Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data

You may have missed

from-crisis-to-control-spains-strategic-victory-over-covid-19-and-the-whos-global-endorsement

From Crisis to Control: Spain’s Strategic Victory Over COVID-19 and the WHO’s Global Endorsement

Asep Darmawan November 7, 2026
groundbreaking-cambridge-study-reveals-bilateral-salpingo-oophorectomy-dramatically-reduces-early-death-risk-in-brca1-2-breast-cancer-patients

Groundbreaking Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients

Asro November 7, 2026
landmark-real-world-study-demonstrates-repathas-superiority-over-ezetimibe-in-reducing-heart-attack-risk

Landmark Real-World Study Demonstrates Repatha’s Superiority Over Ezetimibe in Reducing Heart Attack Risk

Suro Senen November 7, 2026
unmasking-male-breast-cancer-jakes-journey-from-shock-to-advocacy

Unmasking Male Breast Cancer: Jake’s Journey from Shock to Advocacy

Nana Wu November 7, 2026